More throughput is not a good thing if the hospital is losing money on each patient. (My reply to drbio was a serious joke.) Hospitals by and large do make money on generic chemo, even after factoring in the occupancy cost for the infusion time.
If Medicare doesn’t reimburse Tocosol paclitaxel at a premium rate, the product isn’t going anywhere.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.